European centres report promising Altura endograft experiences

Posted on January 11, 2019
Archive : January 2019
Category : Press Releases

Altura Endograft System (Lombard Medical)

This article is an advertorial by Lombard Medical.

Four-year results of a clinical trial experience of 90 endovascular aneurysm repair (EVAR) patients treated with the Altura endograft system (Lombard Medical) were presented at the 2018 VEITHsymposium (13–17 November, New York, USA) by Dainis Krievins of the Pauls Stradins Clinical University Hospital in Riga, Latvia. The trial included the first-in-human implants, with the majority of recent cases performed using the commercial version of the graft.

The trial pooled 90 patients with abdominal aortic aneurysms, enrolled between 2011 and 2015. Patient demographics and anatomy were “typical for EVAR”, Krievins said, in terms of aneurysm size, neck length, and angulation. Patients were followed up with CT and clinical evaluation at 30 days, six months, and annually post-implant for up to five years (mean follow-up time in this report was 2.7 years). The CT images were evaluated by a core lab.

“We are all familiar with the complexities of EVAR which include complex aortic and iliac anatomies which frequently require complex devices to resolve them”, Krievins said. “Gate cannulation, snaring and polymer handling can lead to complex procedures of unpredictable duration. This can make planning surgical lists around EVAR cases inefficient, impacting through and the overall costs of the procedure. The Altura stent-graft was designed to make EVAR cases a little simpler for physicians and to give better predictability for the duration of the case.”

Krievins explained Altura uses materials such as nitinol and polyester fabric to create “a very differentiated stent graft construct in the form of kissing D endografts. These grafts are repositionable during deployment, do not involve gate cannulation and their 14F delivery systems all permit injection of contrast.”

READ MORE: https://vascularnews.com/european-centres-report-promising-altura-endograft-experiences/

Our website makes use of non-invasive (no personal data) cookies to provide you with an enhanced user experience. By continuing to use the site, you consent to this.Close More
The UK Law now requires us to get consent from you for the use of cookies.

A cookie is a small file containing text and numbers generated by the website and passed from your browser back to our website when you revisit the site.

A cookie is used here to allow you to navigate the site, log in etc. Without this cookie (called a session cookie), this site would not work properly and so this has already been set.

We use a popular statistics tool called Google Analytics which uses non invasive cookies to allow us to find out how effective our marketing is, based on referencing how you got to our website (search engine, direct, or from another site etc).

We use an animation based rotating image which uses a cookie to know which image was last displayed so that as you move from page to page you are not seeing the same image every time.

We can also make use of third party services such as video clip players which can set cookies, for example to enable them to know that you part played a video clip previously, or to store customised settings such as brightness or volume. Close
International Site Twitter | Lombard MEdical LimitedLinkedIn | Lombard Medical Limited
About Us | Careers | Terms | Contact Us | Site Map
powered by webboutiques.co.uk 

Our website makes use of non-invasive (no personal data) cookies to provide you with an enhanced user experience. By continuing to use the site, you consent to this.